Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions

Example Bundle: ePI document Bundle for Enbrel 25 mg powder for solution for injection Package Leaflet for language en

Composition category: Raw
Composition status: final

B. Package Leaflet

unavailable

Package leaflet: Information for the user

unavailable

What is in this leaflet

unavailable

1. What Enbrel 25 mg powder for solution for injection is and what it is used for

unavailable

2. What you need to know before you take Enbrel 25 mg powder for solution for injection

unavailable

3. How to take Enbrel 25 mg powder for solution for injection

unavailable

4. Possible side effects

unavailable

5. How to store Enbrel 25 mg powder for solution for injection

unavailable

6. Contents of the pack and other information

unavailable

Enbrel 25 mg powder for solution for injection

IDS: zz

Full name: Enbrel 25 mg powder for solution for injection

- Invented name part: Enbrel

- Scientific name part: Etanercept

- Strength part: 25 mg

- Pharmaceutical dose form part: powder for solution for injection

Name usage: English (Norway)

Authorised dose form:

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: active

Product classification:

Marketing Authorisation 1 of 1

Authorisation number: EU/1/99/126/003

Region:

Marketing authorisation holder: Pfizer Europe MA EEIG

Identifier:

  • ORG-100011459

Status: Active (2009-11-26T13:28:17Z)

Package 1 of 1

PMSWI: EU/1/99/126/003

Description:

Marketing status:

Pack size:

  • 25

Package: 1 Box (Cardboard)

Containing:

Package: 28 Blister (PolyVinyl Chloride)

Containing:

Manufactured Item

Dose form: Powder for solution for injection

Unit of presentation: Vial

Ingredient

Role: Excipient

Substance: SUCROSE

Ingredient

Role: Excipient

Substance: MANNITOL

Ingredient

Role: Active

Substance: Etanercept

Ingredient

Role: Excipient

Substance: TROMETHAMINE

Administrable Product (1 of 1)

Dose form: Powder for solution for injection

Unit of presentation: Vial

Route of administration:

  • Subcutaneous use

Ingredients:

Ingredient

Role: Excipient

Substance: SUCROSE

Ingredient

Role: Excipient

Substance: MANNITOL

Ingredient

Role: Active

Substance: Etanercept

Ingredient

Role: Excipient

Substance: TROMETHAMINE